Markets

Biotech ETF Investing is Hot, Can Get Hotter

Up more than 42% year-to-date, the SPDR S&P Biotech ETF (NYSEArca: XBI), one of the largest biotechnology ETFs, is one of this year's best-performing non-leveraged ETFs. That does not mean XBI's run is over. Some market observers argue the opposite is true. Biotech ETFs soared even after it became apparent Senate Republicans' efforts to replace [...] Click to read more at ETFtrends.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article was provided by our partner Tom Lydon of etftrends.com.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

ETFs